Spironolactone inhibits the activity of the Na+/H+ exchanger in the aorta of mineralocorticoid-induced hypertensive rats

Juan E. Carreño, Fernando J. Verdugo, Felipe Contreras, Felipe A. Montellano, Sebastian Veloso, Kurt A. Schalper, Mauricio Sandoval, Sandra Villanueva, Elisa Marusic, Carlos Ernesto Irarrazabal Muñoz

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Introduction: Aldosterone can induce changes in the expression or activity of Na+/H+ exchanger isoform 1 (NHE-1) in vascular smooth muscle cells. We aimed to clarify whether chronic mineralocorticoid receptor activation exerts an effect on the activity of NHE-1 in the aorta of mineralocorticoid-induced hypertensive rats. Methods: Uninephrectomized male Sprague-Dawley rats received subcutaneously 10 mg/week of desoxycorticosterone (DOCA) with or without 20 mg/kg of spironolactone, or vehicle alone (n = 20). After four weeks of treatment, the animals were sacrificed; the aorta was excised for subsequent studies, including histological analysis, RT-PCR, Western blot, measurement of NHE-1 activity and vascular contractility in the presence or absence of the selective NHE-1 inhibitor ethyl-isopropyl amiloride (EIPA). Results: Chronic DOCA treatment increased the NHE-1 activity, systolic and diastolic blood pressure, and aortic wall thickness. All these effects were prevented by co-treatment with Spironolactone (p < 0.05). Phenylephrine-induced vascular contractility was significantly reduced in the DOCA group when EIPA was added in the media (p < 0.05). No significant differences in NHE-1 mRNA or protein levels were detected between groups. Conclusions: Chronic DOCA administration induced functional and morphological alterations in the rat aorta that are partially explained by enhanced NHE-1 activity and prevented by spironolactone. However, we did not observe changes in the NHE-1 transcript or protein levels, suggesting that the effect may be due to post-transcriptional modifications induced by mineralocorticoid receptor activation.

Original languageEnglish
Pages (from-to)1225-1231
Number of pages7
JournalJRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Volume16
Issue number4
DOIs
StatePublished - 1 Dec 2015

Bibliographical note

Publisher Copyright:
© 2015 The Author(s).

Keywords

  • Desoxycorticosterone
  • Mineralocorticoid receptor
  • Mineralocorticoid receptor antagonists
  • Sodium-hydrogen antiporter
  • Vasoconstriction

Fingerprint Dive into the research topics of 'Spironolactone inhibits the activity of the Na<sup>+</sup>/H<sup>+</sup> exchanger in the aorta of mineralocorticoid-induced hypertensive rats'. Together they form a unique fingerprint.

Cite this